SKU: T9901A-233-5mg-TM
Anti-CD22-NMS249
In Stock
Blue Ice
Specifications
| Specification | Details |
|---|---|
| Additional Information | Anti-CD22-NMS249 is an antibody-drug conjugate (ADC) that targets CD22, comprising the humanized anti-CD22 antibody Pinatuzumab, a cleavable linker (Mc-VC-PAB), and the effective payload of DNA topoisomerase II inhibitor PNU-159682. This compound is utilized in the study of non-Hodgkin lymphoma (NHL). |
Resources
PDF
Datasheet
Catalog Number
T9901A-233-5mg-TM
Name
Anti-CD22-NMS249
Price(500 mg)
Pack Size